What is the recommended management for a patient with second-degree atrioventricular (AV) block?

Management of Second-Degree AV Block

For second-degree Mobitz type II AV block, high-grade AV block, or third-degree AV block not caused by reversible causes, permanent pacemaker implantation is recommended regardless of symptoms. For other types of second-degree AV block (Mobitz type I/Wenckebach), permanent pacing should generally be considered only when symptoms correlate with the AV block 1.

Critical Diagnostic Distinction

The management hinges entirely on correctly identifying the type and location of the AV block:

Mobitz Type II (Infranodal) - Requires Pacing

• ECG characteristics: Constant PR intervals before and after a non-conducted P wave, often with bundle branch block pattern
• Location: His-Purkinje system (infranodal)
• Risk: High progression to complete heart block
• Action: Permanent pacemaker indicated regardless of symptoms 1, 2

Mobitz Type I/Wenckebach (AV Nodal) - Usually Benign

• ECG characteristics: Progressive PR prolongation before dropped beat, PR shortens after the block
• Location: AV node (supranodal)
• Risk: Low progression risk
• Action: Pacemaker only if symptomatic 1

2:1 AV Block - Cannot Be Classified

• Cannot determine if Type I or Type II from surface ECG alone
• Clues suggesting infranodal (worse prognosis):
  • Baseline short PR interval
  • Presence of bundle branch block
  • Minimal PR prolongation before block 3
• Consider electrophysiology study if uncertainty affects management

Common Diagnostic Pitfalls

Mobitz type II is commonly overdiagnosed 2. Several conditions mimic it:

• Atypical Wenckebach: PR intervals may appear constant before block but subtle changes occur
• Vagal surge: Simultaneous sinus slowing with AV nodal block mimics Mobitz II but requires stable sinus rate for true diagnosis
• Concealed His bundle extrasystoles: Create pseudo-AV block patterns 2

Drug-Related AV Block: A Critical Decision Point

This represents a major management controversy. The traditional teaching that drug-induced AV block is "reversible" and doesn't require pacing is increasingly challenged by evidence:

The Reality of "Drug-Induced" Block

• Only 28% of patients maintain improved conduction after drug discontinuation without recurrence 4
• True drug-induced AV block is rare; most cases represent drug-unmasking of underlying conduction disease 5
• When temporary pacing is needed, delays in permanent pacing increase risk and are not justified 5

Specific Drug Considerations

• Carvedilol-induced block: Usually resolves (21/24 cases) and rarely recurs 4
• Metoprolol-induced block: Frequently persists or recurs (24/36 cases required pacing) 4
• Digoxin-induced block: Usually improves (28/39 cases) after withdrawal 4

Practical Algorithm for Drug-Related Block

If the patient requires ongoing bradycardic/antiarrhythmic therapy (e.g., for atrial fibrillation):

• Proceed directly to permanent pacing without waiting for drug washout 5
• This is particularly important in elderly or frail patients 5

If the drug can be permanently discontinued:

• Discontinue and observe
• However, recognize that ~50% will ultimately require pacing due to recurrence or persistent block 4
• Consider early pacing in elderly patients rather than prolonged observation

Exercise Testing for Risk Stratification

When the diagnosis or severity is uncertain, exercise stress testing can be valuable:

• Development of 3:1 or 4:1 AV block with exercise suggests infranodal disease and supports pacing even in minimally symptomatic patients 6
• Worsening block with increased heart rate indicates His-Purkinje disease

Shared Decision-Making Considerations

While guidelines emphasize patient autonomy 1, 7, the recommendation must be clear:

• For Mobitz type II, high-grade, or third-degree block: Strongly recommend pacing, explaining high risk of sudden death
• For symptomatic Mobitz type I: Recommend pacing when symptoms correlate with bradycardia
• For asymptomatic Mobitz type I: Observation is reasonable unless progression occurs

Patients have the right to refuse pacemaker therapy, but this decision requires thorough informed consent about mortality risk, particularly with infranodal block 1, 7.

Reversible Causes to Exclude

Before permanent pacing, ensure the following are not present:

• Acute myocardial infarction
• Electrolyte abnormalities (especially hyperkalemia)
• Digitalis toxicity
• Lyme disease or other infectious causes
• Sleep apnea (nocturnal bradycardia alone is not a pacing indication) 1

If truly reversible causes are corrected and block resolves, permanent pacing may be deferred, but close follow-up is essential given high recurrence rates.